|
|
DSpace at RU >
Browsing by Author Casas, M.
Showing results 1 to 9 of 9
| Full Text | Issue Date | Title | Author(s) | | 2011 | DIRAS2 is associated with adult ADHD, related traits, and co-morbid disorders | Reif, A.; Nguyen, T.T.; Weissflog, L.; Jacob, C.P.; Romanos, M., et al |
| 2011 | Predictors of treatment outcome in adults with ADHD treated with OROS(R) methylphenidate | Buitelaar, J.K.; Kooij, J.J.; Ramos-Quiroga, J.A.; Dejonckheere, J.; Casas, M., et al |
| 2011 | Exploring DRD4 and its interaction with SLC6A3 as possible risk factors for adult ADHD: a meta-analysis in four European populations | Sanchez-Mora, C.; Ribases, M.; Casas, M.; Bayes, M.; Bosch, R., et al |
| 2010 | Common variants in the TPH1 and TPH2 regions are not associated with persistent ADHD in a combined sample of 1,636 adult cases and 1,923 controls from four European populations. | Johansson, S.; Halmoy, A.; Mavroconstanti, T.; Jacobsen, K.K.; Landaas, E.T., et al |
| 2010 | Attention deficit hyperactivity disorder in adults. | Rosler, M.; Casas, M.; Konofal, E.; Buitelaar, J.K. |
| 2010 | Multicenter analysis of the SLC6A3/DAT1 VNTR haplotype in persistent ADHD suggests differential involvement of the gene in childhood and persistent ADHD. | Franke, B.; Vasquez, A.A.; Johansson, S.; Hoogman, M.; Romanos, J., et al |
| 2010 | Meta-analysis of brain-derived neurotrophic factor p.Val66Met in adult ADHD in four European populations. | Sanchez-Mora, C.; Ribases, M.; Ramos-Quiroga, J.A.; Casas, M.; Bosch, R., et al |
| 2009 | Safety and tolerability of flexible dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. | Buitelaar, J.K.; Ramos-Quiroga, J.A.; Casas, M.; Kooij, J.J.; Niemela, A., et al |
| 2008 | A randomized, placebo-controlled trial of three fixed dosages of prolonged-release OROS methylphenidate in adults with attention-deficit/hyperactivity disorder. | Medori, R.; Ramos-Quiroga, J.A.; Casas, M.; Kooij, J.J.; Niemela, A., et al |
Showing results 1 to 9 of 9
|